AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CISPLATINE
22 registrations across 3 African markets— 13 active
Markets with CISPLATINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CYTOCIS Solution injectable pour perfusion / 50mg/50ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Aug 2019 |
| CYTOCIS Solution injectable pour perfusion / 100 mg/100ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Aug 2019 |
| CYTOCIS Solution injectable pour perfusion / 25 mg/25ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Aug 2019 |
| SINPLATIN Solution injectable pour perfusion / 1 mg/ml | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| SINPLATIN 50 MG Solution injectable pour perfusion / 1 mg/ml | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| CISPLATINE VIATRIS Solution injectable / 25 MG | 🇹🇳Tunisia | VIATRIS SANTE | expired | Apr 2001 |
| CISPLATIN-EBEWE Solution injectable / 50 MG | 🇹🇳Tunisia | EBEWE Pharma | expired | May 1998 |
| CISPLATIN-EBEWE Solution injectable / 10 MG | 🇹🇳Tunisia | EBEWE Pharma | expired | May 1998 |
| CISPLATIN-EBEWE Solution injectable / 25 MG | 🇹🇳Tunisia | EBEWE Pharma | expired | Sept 1995 |
| CISPLATINE SANDOZ solution injectable / 50 mg / 100 ml | 🇸🇳Senegal | SANDOZ GMBH | active | — |
| CISPLATINE EBEWE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| PLATAMINE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| PLATAMINE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE COOPER SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE MYLAN SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE MYLAN SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE EBEWE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CEPLATIN SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE COOPER SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE MYLAN SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CEPLATIN SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| CISPLATINE EBEWE SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
CISPLATINE in Africa — Regulatory Overview
CISPLATINE is registered across 3 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 22 registrations, 13 (59%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.